Cardlytics, Inc. (NASDAQ:CDLX) Receives $3.50 Consensus PT from Analysts

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) has been given an average rating of "Hold" by the seven ratings firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $3.50.

Several analysts have recently weighed in on CDLX shares. Needham & Company LLC reaffirmed a "hold" rating on shares of Cardlytics in a research note on Thursday, March 13th. Lake Street Capital dropped their target price on Cardlytics from $3.00 to $2.50 and set a "hold" rating on the stock in a research report on Thursday, May 8th. Finally, Evercore ISI decreased their price objective on Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a research note on Thursday, March 13th.

Cardlytics Trading Up 6.7%

CDLX traded up $0.11 on Friday, reaching $1.76. 797,528 shares of the company traded hands, compared to its average volume of 995,814. The company has a market cap of $92.14 million, a P/E ratio of -0.49 and a beta of 1.25. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 2.62. Cardlytics has a one year low of $1.22 and a one year high of $9.48. The firm has a fifty day simple moving average of $1.79 and a two-hundred day simple moving average of $2.41.

Institutional Investors Weigh In On Cardlytics

Institutional investors have recently added to or reduced their stakes in the stock. Intech Investment Management LLC boosted its stake in Cardlytics by 31.3% during the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after purchasing an additional 4,607 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Cardlytics by 46.0% during the 4th quarter. Wells Fargo & Company MN now owns 21,106 shares of the company's stock valued at $78,000 after acquiring an additional 6,649 shares during the period. Global Retirement Partners LLC grew its position in Cardlytics by 54.7% in the 4th quarter. Global Retirement Partners LLC now owns 19,800 shares of the company's stock valued at $73,000 after acquiring an additional 7,000 shares in the last quarter. Geode Capital Management LLC increased its stake in Cardlytics by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company's stock worth $3,936,000 after purchasing an additional 7,561 shares during the period. Finally, Brooktree Capital Management boosted its stake in shares of Cardlytics by 4.5% in the fourth quarter. Brooktree Capital Management now owns 175,210 shares of the company's stock valued at $650,000 after purchasing an additional 7,568 shares during the period. Institutional investors and hedge funds own 68.10% of the company's stock.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.